NCT02605785

A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 332 (estimated)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 35 Years
• Healthy volunteers: Accepted

Summary

This study is designed to learn more about overall tau burden in the brain of patients with Progressive Supranuclear Palsy (PSP).

Conditions

• Progressive Supranuclear Palsy

Interventions

Type	Name	Description
DRUG	F-18 AV 1451	Tau PET scan

Timeline

• Start date: 2015-11-01
• Primary completion: 2030-01-01
• Completion: 2030-01-01
• First posted: 2015-11-16
• Last updated: 2025-12-15

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study